Tretinoin NDC 68071-3945

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-3945Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-3945Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-3945-2	68071394502	1 TUBE in 1 CARTON (68071-3945-2) / 20 g in 1 TUBEMarketed from Jan 9, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tretinoin
Generic name (nonproprietary): tretinoin
Active ingredients: Tretinoin — .25 mg/g
Dosage form: Cream
Route: Topical
Labeler: NuCare Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075264
Marketing start: Jun 15, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 68071-3945_47fc44a9-f3ed-a612-e063-6394a90a16f7SPL ID 47fc44a9-f3ed-a612-e063-6394a90a16f7SPL set ID 47fc341b-8cff-9d63-e063-6394a90abdfdRxCUI 106302UNII 5688UTC01RUPC 0368071394528
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071394502 followed by a unit qualifier and the quantity

Package 68071-3945-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 9, 2026.

Indications (excerpt from the label)

Indications and Usage: Tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075264

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075264
Product	Strength	Form · route	Labeler	Product NDC
Tretinoin	Tretinoin .25 mg/g	CreamTopical	Bryant Ranch Prepack	72162-2135
Tretinoin	Tretinoin .25 mg/g	CreamTopical	A-S Medication Solutions	50090-3128
Tretinoin	Tretinoin .25 mg/g	CreamTopical	Padagis US LLC	0574-2225
Tretinoin	Tretinoin .25 mg/g	CreamTopical	Preferred Pharmaceuticals Inc.	68788-4069